These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 15944050)

  • 1. Relevance of high-dose chemotherapy in solid tumours.
    Nieboer P; de Vries EG; Mulder NH; van der Graaf WT
    Cancer Treat Rev; 2005 May; 31(3):210-25. PubMed ID: 15944050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive chemotherapy with stem cell support-experience in pediatric solid tumours.
    Pinkerton CR
    Bull Cancer; 1995; 82 Suppl 1():61s-65s. PubMed ID: 7626856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [High-dose chemotherapy and autologous bone marrow transplantation in solid tumors. A review].
    Handberg J; Hansen SW
    Ugeskr Laeger; 1996 Jul; 158(29):4175-80. PubMed ID: 8701532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy dose intensity facilitated by use of lenograstim--implications for quality of life and survival.
    Gisselbrecht C
    Eur J Cancer; 1994; 30A Suppl 3():S30-3. PubMed ID: 7535070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose chemotherapy in adult sarcomas: no standard yet.
    Seynaeve C; Verweij J
    Semin Oncol; 1999 Feb; 26(1):119-33. PubMed ID: 10073568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose chemotherapy with autologous hematopoietic stem cell support for solid tumors in adults.
    Pedrazzoli P; Rosti G; Secondino S; Carminati O; Demirer T; ; ;
    Semin Hematol; 2007 Oct; 44(4):286-95. PubMed ID: 17961729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curative cancer chemotherapy.
    Frei E
    Cancer Res; 1985 Dec; 45(12 Pt 1):6523-37. PubMed ID: 2998603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose chemotherapy with stem cell reinfusion and growth factor support for solid tumors.
    de Vries EG; de Graaf H; Boonstra A; van der Graaf WT; Mulder NH
    Stem Cells; 1995 Nov; 13(6):597-606. PubMed ID: 8590861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose chemotherapy in ovarian carcinoma.
    Herrin VE; Thigpen JT
    Semin Oncol; 1999 Feb; 26(1):99-105. PubMed ID: 10073566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small cell lung cancer: a randomized trial.
    Leyvraz S; Pampallona S; Martinelli G; Ploner F; Perey L; Aversa S; Peters S; Brunsvig P; Montes A; Lange A; Yilmaz U; Rosti G;
    J Natl Cancer Inst; 2008 Apr; 100(8):533-41. PubMed ID: 18398095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose therapy for breast cancer.
    Hudis CA; Münster PN
    Semin Oncol; 1999 Feb; 26(1):35-47. PubMed ID: 10073560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [High-dose chemotherapy for metastatic breast cancer].
    Lalle M; De Rosa L; Perillo A; Scambia G; D'Aprile M; Antimi M
    Clin Ter; 2004; 155(7-8):305-15. PubMed ID: 15553258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experience with other tumors: breast, ovary, brain tumors and sarcomas].
    Maraninchi D; Droz JP
    Bull Cancer; 1995; 82 Suppl 1():66s-72s. PubMed ID: 7626857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NCCN: High-dose chemotherapy. Applications of high-dose chemotherapy with bone marrow/stem cell support in solid tumors.
    Vaughan WP
    Cancer Control; 2001; 8(6 Suppl 2):50-2. PubMed ID: 11760558
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of neutropenia on delivering planned chemotherapy for solid tumours.
    Khan S; Dhadda A; Fyfe D; Sundar S
    Eur J Cancer Care (Engl); 2008 Jan; 17(1):19-25. PubMed ID: 18181887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-dense chemotherapy for primary breast cancer.
    Kümmel S; Rezai M; Kimmig R; Schmid P
    Curr Opin Obstet Gynecol; 2007 Feb; 19(1):75-81. PubMed ID: 17218856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of high-dose busulfan plus melphalan as consolidation in metastatic Ewing tumors: a study by the Société Française des Cancers de l'Enfant.
    Oberlin O; Rey A; Desfachelles AS; Philip T; Plantaz D; Schmitt C; Plouvier E; Lejars O; Rubie H; Terrier P; Michon J;
    J Clin Oncol; 2006 Aug; 24(24):3997-4002. PubMed ID: 16921053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dose intensity of chemotherapy in small-cell lung carcinoma. Review of comparative studies].
    Sanz Rubiales A; del Valle Rivero ML; Garavís Vicente M; Rey Castro P; López-Lara Martín F
    An Med Interna; 2000 Jul; 17(7):378-85. PubMed ID: 10981338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tandem high-dose chemotherapy with autologous peripheral hematopoietic progenitor cell rescue as consolidation therapy for patients with high-risk Ewing family tumors.
    Burke MJ; Walterhouse DO; Jacobsohn DA; Duerst RE; Kletzel M
    Pediatr Blood Cancer; 2007 Aug; 49(2):196-8. PubMed ID: 17417796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors in germ cell tumour patients with relapse or progressive disease after first-line chemotherapy: evaluation of a prognostic score for survival after high-dose chemotherapy.
    Sammler C; Beyer J; Bokemeyer C; Hartmann JT; Rick O
    Eur J Cancer; 2008 Jan; 44(2):237-43. PubMed ID: 18055194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.